Combination Therapy Current Events | Combination Therapy News | 3
|
| Page
3 of
50 |
998 Results |
|
|
|
Sort By:
Page Views | Date |
Dual gene therapy suppresses lung cancer in preclinical test
Combination gene therapy delivered in lipid-based nanoparticles drastically reduces the number and size of human non-small cell lung cancer tumors in mice. view more (2007-01-15)
Vitamin E, selenium and soy in combination does not prevent prostate cancer
The combination therapy of vitamin E, selenium and soy does not prevent the progression from high-grade prostatic intraepithelial neoplasia (HGPIN) to prostate cancer, according to the new research presented at the 104th Annual Scientific Meeting of the American Urological Association (AUA). view more (2009-04-27)
How can we know early who will benefit from tumor target therapy?
The precise tailoring of tumor target treatment for patients with cancer is an unmet challenge. The goal is to only administer treatments that have a high probability of being effective. view more (2007-11-26)
Study finds limited options for backup HIV treatment in some developing countries
Thai researchers have discovered that patients who fail treatment with a commonly used, inexpensive, first-line antiretroviral therapy (ART) are also usually resistant to other, similar drugs, leaving progressively fewer options for replacement therapies. view more (2007-01-09)
Study finds limited options for backup HIV treatment in some developing countries
Thai researchers have discovered that patients who fail treatment with a commonly used, inexpensive, first-line antiretroviral therapy (ART) are also usually resistant to other, similar drugs, leaving progressively fewer options for replacement therapies. view more (2007-01-09)
Drug therapy reduces neuroblastoma tumor growth in pre-clinical investigation
Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have discovered a new drug combination that significantly hinders tumor growth in neuroblastoma, a childhood cancer. view more (2009-04-27)
New treatment combination proves safe for head and neck cancer patients
Patients undergoing treatment for advanced head and neck cancers may respond well to the addition of gefinitib to chemotherapy. view more (2009-06-01)
Chemo-radiation before prostate removal may prevent cancer recurrence
Researchers in the Oregon Health & Science University Knight Cancer Institute and the Portland Veterans Affairs Medical Center have found a combination of radiation therapy and chemotherapy given before prostate removal is safe and may have the potential to reduce cancer recurrence and improve patient survival. view more (2009-11-05)
Study shows drug combination improves outcome for advanced non-small cell lung cancer
A new, international study found that the combination of two drugs delays disease progression for patients with advanced non-small cell lung cancer (NSCLC). view more (2009-06-01)
Combination drug therapy could substantially improve symptoms of rheumatoid arthritis (pp 670, 675)
The combination of two drugs - both partly effective for rheumatoid arthritis patients when given individually - could be an important development in substantially reducing symptoms and joint destruction for people with rheumatoid arthritis, conclude authors of a study in this week's issue of THE LANCET. Rheumatoid arthritis affects around 1% of... view more... (2004-02-25)
Hormone therapy associated with reduced colorectal cancer risk
The combination of estrogen plus progestin, which women stopped taking in droves following the news that it may increase their risk of breast cancer, may decrease their risk of colorectal cancer, according to a report published in the January issue of Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer... view more... (2009-01-08)
Penn researchers identify new combination therapy that promotes cancer cell death
Researchers at the University of Pennsylvania School of Medicine identified a combination therapy as a way to sensitize resistant human cancer cells to a treatment currently being tested in clinical trials. view more (2007-07-17)
Older drugs may be good stopgap treatment for malaria in Africa
A combination of older malaria drugs could treat malaria efficiently in some parts of Africa until a newer antimalarial drug called is widely available in those areas, a new review of recent studies suggests. view more (2006-01-25)
The Importance of Early Intervention in the Treatment of Rheumatoid Arthritis
Study Indicates that Even a Few Months Delay in Implementing Drug Therapy Increases Long-Term Disease Severity and Joint Damage Findings Underscore the Urgency for Rapid Access of Patients to Specialist Care In a recent study, researchers found that the delay of treatment to patients with early Rheumatoid... view more... (2002-03-27)
Co-operation between GSF and clinic improves outlook for sarcoma patients: Effectiveness of local, deep hyperthermia proved in phase III study
Hyperthermia, combined with chemotherapy, improves the chances of healing and survival of patients with low-lying, soft tissue sarcomas. view more (2007-07-16)
Standard treatment for lung cancer should be changed, say scientists
Embargoed: 09.00 hrs CET Tuesday 23 September 2003 Copenhagen, Denmark: Patients with non-small cell lung cancer (NSCLC) are more likely to survive if they have chemotherapy after surgery than if they have surgery alone, said a scientist at ECCO 12 The European Cancer Conference in Copenhagen today (Tuesday 23 September). Dr. Bengt Bergman, of the... view more... (2003-09-21)
Combination therapy packs 1-2 punch against melanoma
Disabling a protein frequently found in melanoma tumors may make the cancer more vulnerable to chemotherapy, according to a pilot study led by researchers in the Duke Comprehensive Cancer Center. view more (2008-06-02)
Blood cholesterol levels predict risk of heart disease due to hormone therapy
A new analysis of a subgroup of participants in the Women's Health Initiative (WHI) hormone therapy clinical trials suggests that healthy, postmenopausal women whose blood cholesterol levels are normal or lower are not at increased, short-term risk for heart attack when taking hormone therapy. view more (2008-05-27)
Certain HIV treatment less effective when used with anti-TB therapy
Patients receiving rifampicin-based anti-tuberculosis therapy are more likely to experience virological failure when starting nevirapine-based antiretroviral therapy, an HIV treatment that is widely used in developing countries because of lower cost, than when starting efavirenz-based antiretroviral therapy. view more (2008-08-04)
Combination of ASA and clopidogrel reduces heart attack risk in patients with acute coronary syndrome
In order to better prevent blood clots, clopidogrel can be prescribed to patients with acute ischaemia of the heart muscle, in addition to acetylsalicylic acid (ASA). The Institute for Quality and Efficiency in Health Care (IQWiG) has now investigated whether the combination of clopidogrel and ASA actually has a higher benefit for patients than... view more... (2009-04-22)
|
|
| Page
3 of
50 |
998 Results |
|
|
|
Sort By:
Page Views | Date |
|
